21 search results for: biomarkers

Join Prof. Sietze Reitsma for an insightful presentation that will delve into identifying and leveraging key characteristics to optimize patient management and treatment outcomes.

Learn about the multifaceted burden of uncontrolled pediatric asthma on patients and their caregivers.

Join Dr. Miguel Lanz as he explains the clinical utility of FeNO as a biomarker of severe asthma.

This infographic outlines how endotyping, phenotyping, and genotyping are interrelated concepts that are crucial for improving the way patients with COPD are characterized and how understanding these concepts can better optimize patient care

Explore how blood eosinophil counts can fluctuate over time in patients with COPD and how repeat measurements may help reveal patterns of underlying type 2 inflammation.

Learn how to identify chronic obstructive pulmonary disease (COPD) patients with type 2 inflammation using blood eosinophil (EOS) levels, understand the associated risks, and recognize factors that may influence EOS counts.

Examine underlying type 2 inflammation as a driver of airway hyperresponsiveness in patients with asthma.

Explore the concept of disease modification in atopic dermatitis through this interactive infographic, which highlights potential considerations such as optimal sustained disease control, subclinical inflammation, the pathophysiology of AD, and atopic/non-atopic comorbidities.

Learn about FEV1pp and the downstream effects of lung function decline in children with severe asthma.